1
Masaru Otani, Tetsu Saito, Shuzo Satoi, Junzo Mizoguchi, Naoki Muto: Amino sugar compound. Toyo Jozo company, Craig & Antonelli, March 3, 1981: US04254256 (18 worldwide citation)

An amino sugar compound represented by the general formula: ##STR1## (wherein m is an integer of 0 to 8, n is an integer of 1 to 8 and m+n is an integer of 1 to 8) has strong glycosidase inhibiting action and is produced by culturing an amino sugar compound producing microorganisms belonging to Stre ...


2

3
Jau Yann Wu, Li Feng Liu, Kuan Ju Pan, Hao Yu Tseng, Jian Ching Wu: Use of fluorescent saccharide-based derivative. I Shou University, Jianq Chyun IP Office, November 25, 2014: US08895261

The disclosure provides a use of a fluorescent saccharide-based derivative in cell detection. The fluorescent saccharide-based derivative is obtained from a reactive material through an imine formation reaction, and the reactive material is selected from a composition (A) or a composition (B). The c ...


4
Yokota Takeshi, Haramura Masayuki, Haishi Takeshi, Matsumoto Masahiko: Agent for removing biological film. Chugai Pharmaceut, March 26, 1996: JP1996-081488

PURPOSE: To obtain a new compound (salt) comprising a specific amino-sugar, having a biological film-removing or degrading action, etc., effective for the therapy of intractable biological film infectious diseases caused by biological film-covered bacteria, and useful for biological film-removing ag ...


5
USE OF FLUORESCENT SACCHARIDE-BASED DERIVATIVE. I SHOU UNIVERSITY, April 24, 2014: US20140113325-A1

The disclosure provides a use of a fluorescent saccharide-based derivative in cell detection. The fluorescent saccharide-based derivative is obtained from a reactive material through an imine formation reaction, and the reactive material is selected from a composition (A) or a composition (B). The c ...


6
SACCHARIDE-BASED BIOMARKERS AND THERAPEUTICS. September 21, 2017: US20170267777-A1

Provided are antibodies that specifically bind to an epitope containing N-acetylglucosamine or N-acetyl-galactosamine expressed by a cancer cell or an inflammatory cell. Also provided are compositions including these antibodies, as well as polynucleotides, vectors, host cells, and methods useful for ...